ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab.

Neil E Bhola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.